InvestorsHub Logo
icon url

November61

04/21/21 2:16 PM

#158975 RE: jesuslovzu #158971

It will go DOWN! REAL TOXIC COMPANY

In other words, it is a SCAM selling shares while keeping carrots in front of anyone nose.

The CEO will tell AGAIN. Q1...." we fell short ...."

GLTY
icon url

NewJerichoMan

04/21/21 2:44 PM

#158982 RE: jesuslovzu #158971

What is the 'break even' point



IMO, $500K is the number. Sounds low, right? Don't worry, there's a caveat.

They did $2.5M in 2020 and $700K in 2019. The revenue stream(s) that make up those figures come from cleaning (hospital acquired infections) and CoVid. Going forward, CoVid will diminish and cleaning / disinfecting will be what it always what, but with a larger footprint.

It appears there is an uncommunicated move afoot to transition the company from "what it was" to more focused on Oil & Gas and Agriculture.

If they can tell the story (big ask) of why the company will succeed in this transition, $500K ($2M per year in annual sales) is a decent starter position.

But the new focus / revenue streams have to have much greater potential over the existing one(s), maybe even an order of magnitude higher, to justify the current market cap (~$13.5M or ~$24M fully diluted).

Cleaning the fooking cap like they said they already did (447M warrants still existing) would go a long ways also.

icon url

snow

04/21/21 3:38 PM

#158990 RE: jesuslovzu #158971

jesuslovzu My perspective is that the first quarter will be very weak but that revenues may or may not improve strongly during the remainder of the year. I have seen little suggesting good revenues during the first quarter. Later a lot will hinge on oil & gas and perhaps the UK.
icon url

Evaluate

04/22/21 2:03 AM

#159040 RE: jesuslovzu #158971

Here is a guess:
“Breakeven” = $0.017 @ $600K Revenue Q1 (= no improvement over 2020 annual/quarterly run rate)
$0.04 at $1.25 M
$0.05 at $1.5 M
$0.06 at $1.75 M
$0.07 at $2.0 M
$0.08 at $2.25 M
$0.09 at $2.5M (= $10 M annual run rate)